Dr. Mark A. Henderson, MD

Dr. Henderson practices at Columbus Regional Hospital in Columbus, Indiana, part of Columbus Regional Hospital.

Dr. Henderson's NPI, 1841370707, was assigned on October 16, 2006. Dr. Henderson graduated from Indiana University School Of Medicine in 2003. Dr. Henderson's Indiana license number on file is 01061526A.

Dr. Henderson's primary practice is Columbus Regional Hospital, at 2400 E 17th St, Columbus, IN 47201 in Bartholomew County. The practice phone is (812) 379-4441.

Dr. Henderson's primary practice is Columbus Regional Hospital in Columbus, Indiana, part of Columbus Regional Hospital. The medical group on file is Columbus Regional Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Henderson practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Henderson's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Henderson is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Henderson's licenses on file in 2 states: Indiana and Oregon.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation and lung cancer radiation among the conditions Dr. Henderson treats.

CMS data shows 2,646 Medicare services from Dr. Henderson across 21 procedure codes in 2024, for 277 Medicare patients. Medicare paid $179,823 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 277 Medicare patients who saw Dr. Henderson in 2024. The largest group is 75 to 84, with 120 patients. 75% of them have cancer, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Henderson's median patient age at 72, with 52% women.

In 2024, Dr. Henderson wrote 343 Medicare Part D claims for 147 patients. 95% of them were for generic drugs. CMS names the drug for 188 of them, across 9 drugs with 11 or more claims each, at $37,911 in total drug cost. In 2023, CMS named 138 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Henderson for performance year 2024, reported through an alternative payment model (APM). Dr. Henderson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 24 papers to Dr. Henderson, published from 2006 to 2016. 2016 was the busiest year, with 3. The most frequent topics are Radiosurgery, Brain Neoplasms and Lung Neoplasms. Dr. Henderson has published most often in Stereotact Funct Neurosurg. Dr. Henderson's most frequent co-authors are Robert Dale Timmerman, MD, Peter A. Johnstone, MD and Higinia R. Cardenes, MD.

CMS Open Payments shows 50 general payments to Dr. Henderson from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Sirtex Medical Inc paid the most, $189.

Dmand AI lists 1 award for Dr. Henderson.

Dr. Henderson graduated from Indiana University School Of Medicine in 2003. Dr. Henderson is a member of ACR, American Radium Society, ASTRO, ASCO and Indiana Oncology Society.

Dr. Henderson is in network with 17 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.